IMVT Stock Immunovant (IMVT, $26.19) was a top loser this quarter, falling -17.04%

A.I.dvisor
at Tickeron.com
06/19/24
Loading...
IMVT - Immunovant

Loading...

Price: $26.19
Daily change: -$0.61 (-2.28%)
Daily volume: 1M
3-month price change: -$5.38 (-17.04%)
Capitalization: $3.8B
Industry: Biotechnology
Immunovant (IMVT, $26.19) was a top loser over the last three months, falling -1 to $26.19 per share. A.I.dvisor analyzed 892 stocks in the Biotechnology Industry for the 3-month period ending June 18, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
164
Web
https://www.immunovant.com